References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rat VSMC |
Rat (Wistar) vascular smooth muscle cells from thoracic aorta | Rat | vasculature | unknown | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jun 2006; 290: H2459 - H2465 | Link | |||
Rat VSMC |
Rat vascular smooth muscle cells | Rat | vasculature | unknown | plasmid | DOTAP | publication | W. Li et al., Am J Physiol Heart Circ Physiol, Jan 2005; 288: H408 - H415 | |||||
pPSMC |
Porcine primary smooth muscle cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | ||||
pPPAEC |
Porcine primary pulmonary artery endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | B. Wojciak-Stothard et al., Am J Physiol Lung Cell Mol Physiol, Apr 2005; 288: L749 - L760 | Link | |||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | plasmid | Metafectene | publication | K. Renner at al., J. Cell. Physiol., 2012, 227: 398–2411, DOI: 10.1002/jcp.22975 | ||||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | A. Nayebosadri et al., Am J Physiol Cell Physiol, Aug 2013; 305: C309 - C322 | Link | |||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | Y. Riahi et al., Diabetes, Apr 2010; 59: 808 - 818 | Link | ||
PASMC |
Pulmonary artery smooth muscle cells | unknown | vasculature | unknown | plasmid | Metafectene | publication | W. Zhang et al., Sheng Li Xue Bao, Feb 2006; 58(1): 71-6 | |||||
PAEC |
Porcine primary aortic endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene | publication | B. Wojciak-Stothard et al., Am J Physiol Lung Cell Mol Physiol, Jun 2006; 290: L1173 - L1182 | Link | |||
PAEC |
Porcine primary aortic endothelial cells | Swine | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | B. Wojciak-Stothard et al., J.Cell Sci, March 2007;120: 929-942 | Link | |||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | K. Lee et al., Arch. Pharm. Res., 2016, 39:83-93; DOI 10.1007/s12272-015-0687-3 | ||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
hVSMC |
Human vascular (aortic) smooth muscle cells | Human | vasculature | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Cardiovasc Res, Aug 2008; 79: 519 - 526 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Korean Circ. J., 2012, 42: 239-245, doi.org/10.4070/kcj.2012.42.4.239 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | N. Kostopoulou et al., J. Cell Sci., 2021, 134, jcs246892, doi:10.1242/jcs.246892 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Cardiovasc Res, Jan 2013; 97: 143 - 152 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | J. Yang et al., Oncology Reports, 2015, 34: 2745-2751; DOI: 10.3892/or.2015.4223 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jan 2012; 302: H135 - H142 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Bellou et al., Am J Physiol Cell Physiol, Dec 2009; 297: C1477 - C1489 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 |